Quality Of 18 Pharma Companies’

  • 16 Jun 2019

The Bureau of Pharma PSUs of India (BPPI) has found 25 batches of drugs of 18 pharmaceutical companies to be of substandard quality since January 2018.

Relevance of the News: The news highlights the quality of drugs manufactured in India and the related regulatory mechanism.

More on the News:

  • As on February 8 this year, under the Pradhan Mantri Janaushadhi Pariyojana (PMBJP), the BPPI has entered into a contract with 146 pharmaceutical manufacturing companies for procuring generic medicines to be sold through dedicated retail outlets.
  • After procuring the affordable generic drugs from pharmaceutical companies, the BPPI, suppliesthese drugs to various Jan Aushadhi Kendras managed under the Pradhan Mantri Janaushadhi Pariyojana (PMBJP).
  • Out of 18 pharmaceuticals companies, 17 are private, one is a public sector unit (PSU) — Indian Drugs and Pharmaceuticals Limited (IDPL).

Pradhan Mantri Janaushadhi Pariyojana(PMBJP):

  • It is a campaign launched the government to provide quality medicines at affordable prices to the masses through special kendra’s known as Pradhan Mantri Bhartiya Jan Aushadhi Kendra which have been set up to provide quality generic drugs at affordable prices.
  • The project is being implemented by Bureau of Pharma PSUs of India.